MedPath

武汉福星生物药业有限公司

Ownership
-
Established
2002-10-17
Employees
-
Market Cap
-
Website
www.whfxsyyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

118

NMPA:118

Drug Approvals

Sodium Bicarbonate Ringer's Injection

Product Name
碳酸氢钠林格注射液
Approval Number
国药准字H20253601
Approval Date
Mar 11, 2025
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H42021781
Approval Date
Jul 8, 2024
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20244174
Approval Date
Jun 28, 2024
NMPA

Benzyl Alcohol Injection

Product Name
苯甲醇注射液
Approval Number
国药准字H42022998
Approval Date
Aug 2, 2022
NMPA

Benzyl Alcohol Injection

Product Name
苯甲醇注射液
Approval Number
国药准字H42022997
Approval Date
Aug 2, 2022
NMPA

Troxerutin Injection

Product Name
曲克芦丁注射液
Approval Number
国药准字H42023004
Approval Date
Jul 22, 2022
NMPA

Compound Amino Acid Injection(6AA)

Product Name
复方氨基酸注射液(6AA)
Approval Number
国药准字H42022993
Approval Date
Jul 22, 2022
NMPA

Fleroxacin Injection

Product Name
氟罗沙星注射液
Approval Number
国药准字H20058047
Approval Date
Jul 22, 2022
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H42020796
Approval Date
Jul 21, 2022
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H42020797
Approval Date
Jul 21, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.